Search

everythinglearnresearchcommunity

for

Search:↓

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Low prolactin in young women may increase heart and metabolism risks.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

DNA methylation and long non-coding RNAs are key in controlling hair growth in Cashmere goats.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Women with PCOS have more emotional and body image issues than healthy women.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Researchers found a new mutation causing total hair loss from birth.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Hodgkin's lymphoma can show up as hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Non-obese women with hair loss have higher heart disease risk.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

PCOS is a major cause of infertility and requires personalized treatment.